Clinical trial · Interventional
Vasomotor Symptom Alleviation Through Acupuncture in Patients With Prostate Cancer
NCT06472856CI-TRIAL-00104586VASA ProcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A pilot study to assess the acceptability and efficacy of acupuncture in alleviating vasomotor symptoms (hot flushes and night sweats) in Irish patients with prostate cancer receiving androgen deprivation therapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acupuncture | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Acupuncture
- interventionNames
- Procedure: Acupuncture
Primary outcomes (1)
- measure
- Feasibility of the intervention
- timeFrame
- Completed after 6 weeks of acupuncture sessions and repeated 3 months after acupuncture has finished
- description
- Specially designed questionnaire
Secondary outcomes (2)
- measure
- Changes in symptom interference scores
- timeFrame
- Completed after 6 weeks of acupuncture sessions and repeated 3 months after acupuncture has finished
- description
- Changes in the Hot Flash Related Daily Interference Scale (HFRDIS). The scale is measured from 0-10, with lower scores indicating a better outcomes
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All participants must have a histologically confirmed diagnosis of prostate cancer and currently be treated with androgen deprivation therapy with or without additional prostate cancer therapies. * Patients under the care of a Medical Oncologist in either Bons Secours Hospital or Cork University Hospital * All participants must be experiencing moderate to severe vasomotor symptoms as defined by a score of 4 or more on the Hot Flash Index. Exclusion Criteria: * Patients under 18. * Patients with HFI scores below 4. * Patients not currently being treated with androgen deprivation therapy. * Patients with contraindications to acupuncture. * Patients already receiving acupuncture for vasomotor symptoms. * Patients unwilling to participate in the study.
References
Publications (0)
Data not yet available
No reference posted for this study.